FY2023 EPS Estimates for Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS) Boosted by Cantor Fitzgerald themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS – Get Rating) – Equities researchers at HC Wainwright issued their Q1 2023 earnings estimates for Acumen Pharmaceuticals in a report issued on Tuesday, March 28th. HC Wainwright analyst A. Fein forecasts that the company will earn ($0.31) per share for the quarter. HC Wainwright currently has a “Buy” rating and […]
Acumen Pharmaceuticals (NASDAQ:ABOS – Get Rating)‘s stock had its “buy” rating reaffirmed by HC Wainwright in a research note issued to investors on Tuesday, Benzinga reports. They currently have a $15.00 target price on the stock. HC Wainwright’s price objective indicates a potential upside of 274.06% from the company’s current price. Separately, Credit Suisse Group […]